Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes
Epithelial-mesenchymal transition (EMT) is a physiological process that has been recognized to occur during the progression of an increasingly large number of human diseases, including liver fibrosis, cirrhosis, and hepatocellular carcinoma. The activation of transforming growth factor β (TGF-β) sig...
שמור ב:
Main Authors: | Yue‐Lei Chen, Jing Lv, Xiaolei Ye, Mingyu Sun, Qin Xu, Chenghai Liu, Lihua Min, Huiping Li, Ping Liu, Xiaoyan Ding |
---|---|
פורמט: | Artigo |
שפה: | אנגלית |
יצא לאור: |
2011
|
גישה מקוונת: | https://doi.org/10.1002/hep.24254 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.24254 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
פריטים דומים
-
Sorafenib Inhibits Epithelial-Mesenchymal Transition through an Epigenetic-Based Mechanism in Human Lung Epithelial Cells
מאת: Zhang, Juyong, et al.
יצא לאור: (2013) -
Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma
מאת: Tomoyuki Nagai, et al.
יצא לאור: (2011) -
Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
מאת: Yanru Deng, et al.
יצא לאור: (2016) -
Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
מאת: Deng, Yan-Ru, et al.
יצא לאור: (2016) -
The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition
מאת: Zhang, Kun, et al.
יצא לאור: (2019)